• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
RARE

RARE

Ultragenyx Pharmaceutical Inc.

NASDAQHealthcareBiotechnologyUS

USD22.41

+0.63 (+2.89%)

Rating:C+

Company Profile

CEO

Emil D. Kakkis

IPO Date

2014-01-31

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$21.85

Prev. Close

$21.78

Day Low

$21.80

Day High

$22.59

52W Low

$18.29

52W High

$42.37

Market Cap

$2.21B

Volume

1.77M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Analyst Consensus
Buy

Strong Buy

0

Buy

27

Hold

5

Sell

1

Strong Sell

0

Analyst Grades
DateFirmPreviousNew GradeAction
22 Oct 2024Cantor FitzgeraldOverweightOverweightmaintain
21 Oct 2024TD CowenBuyBuymaintain
1 Oct 2024Cantor FitzgeraldOverweightOverweightmaintain
26 Sept 2024
RBC Capital
Outperform
Outperform
maintain
20 Sept 2024Cantor FitzgeraldOverweightOverweightmaintain
16 Sept 2024Cantor FitzgeraldOverweightOverweightmaintain
5 Aug 2024BarclaysOverweightOverweightmaintain
2 Aug 2024Wells FargoOverweightOverweightmaintain
2 Aug 2024WedbushNeutralNeutralmaintain
2 Aug 2024Goldman SachsBuyBuymaintain